🇨🇦 levofloxacin-based triple therapy for 10 days in Canada

levofloxacin-based triple therapy for 10 days (levofloxacin-based triple therapy for 10 days) regulatory status in Canada.

Marketing authorisation

levofloxacin-based triple therapy for 10 days in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is levofloxacin-based triple therapy for 10 days approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for levofloxacin-based triple therapy for 10 days in Canada?

National Taiwan University Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.